1 – 10 of 48
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
A Randomized, Placebo-Controlled, Single-Center, Crossover Study to Evaluate the Effects of Pre-Meal Whey Protein Microgel on Post-Prandial Glucometabolic and Amino Acid Response in People with Type 2 Diabetes and Overweight or Obesity
- Contribution to journal › Article
-
Mark
Glucose-dependent insulinotropic polypeptide (GIP)
- Contribution to journal › Scientific review
- 2024
-
Mark
RNA sequencing unravels novel L cell constituents and mechanisms of GLP-1 secretion in human gastric bypass-operated intestine
Miskelly, Michael G. LU ; Lindqvist, Andreas LU ; Piccinin, Elena ; Hamilton, Alexander LU ; Cowan, Elaine LU
; Nergård, Bent Johnny
; Del Giudice, Rita
LU
; Ngara, Mtakai
LU
; Cataldo, Luis R.
LU
and Kryvokhyzha, Dmytro
LU
, et al.
(2024)
In Diabetologia
67(2).
p.356-370
- Contribution to journal › Article
-
Mark
The dual incretin co-agonist tirzepatide increases both insulin secretion and glucose effectiveness in model experiments in mice
- Contribution to journal › Article
-
Mark
The Association of Cardiometabolic, Diet and Lifestyle Parameters With Plasma Glucagon-like Peptide-1 : An IMI DIRECT Study
- Contribution to journal › Article
- 2023
-
Mark
Anti-Incretin Gut Features Induced by Feed Supplementation with Alpha-Amylase : Studies on EPI Pigs
Pierzynowska, Kateryna LU
; Wychowański, Piotr
; Zaworski, Kamil
; Woliński, Jarosław
LU
; Donaldson, Janine
and Pierzynowski, Stefan
LU
(2023)
In International Journal of Molecular Sciences
24(22).
- Contribution to journal › Article
-
Mark
Inclusion of Oat Polar Lipids in a Solid Breakfast Improves Glucose Tolerance, Triglyceridemia, and Gut Hormone Responses Postprandially and after a Standardized Second Meal: A Randomized Crossover Study in Healthy Subjects
Hossain, Mohammad Mukul LU ; Tovar, Juscelino LU
; Cloetens, Lieselotte
LU
and Nilsson, Anne
LU
(2023)
In Nutrients
15(20).
- Contribution to journal › Article
-
Mark
Paradigm Shift in the Management of Metabolic Diseases—Next-Generation Incretin Therapy
- Contribution to journal › Scientific review
-
Mark
Contribution of GIP and GLP-1 to the Insulin Response to Oral Administration of Glucose in Female Mice
- Contribution to journal › Article
- 2022
-
Mark
In vivo drug discovery for increasing incretin-expressing cells identifies DYRK inhibitors that reinforce the enteroendocrine system
- Contribution to journal › Article